These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
128 related items for PubMed ID: 17418102
1. 15-deoxy-Delta12,14-prostaglandin J2-induced down-regulation of endothelial nitric oxide synthase in association with HSP70 induction. Hwang J, Lee HI, Chang YS, Lee SJ, Kim KP, Park SI. Biochem Biophys Res Commun; 2007 May 25; 357(1):206-11. PubMed ID: 17418102 [Abstract] [Full Text] [Related]
2. Protein thiol modification by 15-deoxy-Delta12,14-prostaglandin J2 addition in mesangial cells: role in the inhibition of pro-inflammatory genes. Sánchez-Gómez FJ, Cernuda-Morollón E, Stamatakis K, Pérez-Sala D. Mol Pharmacol; 2004 Nov 25; 66(5):1349-58. PubMed ID: 15317873 [Abstract] [Full Text] [Related]
3. Activation of peripheral kappa/delta opioid receptors mediates 15-deoxy-(Delta12,14)-prostaglandin J2 induced-antinociception in rat temporomandibular joint. Pena-dos-Santos DR, Severino FP, Pereira SA, Rodrigues DB, Cunha FQ, Vieira SM, Napimoga MH, Clemente-Napimoga JT. Neuroscience; 2009 Nov 10; 163(4):1211-9. PubMed ID: 19647045 [Abstract] [Full Text] [Related]
6. Inhibition of estrogen receptor beta-mediated human telomerase reverse transcriptase gene transcription via the suppression of mitogen-activated protein kinase signaling plays an important role in 15-deoxy-Delta(12,14)-prostaglandin J(2)-induced apoptosis in cancer cells. Kondoh K, Tsuji N, Asanuma K, Kobayashi D, Watanabe N. Exp Cell Res; 2007 Oct 01; 313(16):3486-96. PubMed ID: 17706193 [Abstract] [Full Text] [Related]
7. Translational regulation of cyclin D1 by 15-deoxy-delta(12,14)-prostaglandin J(2). Campo PA, Das S, Hsiang CH, Bui T, Samuel CE, Straus DS. Cell Growth Differ; 2002 Sep 01; 13(9):409-20. PubMed ID: 12354750 [Abstract] [Full Text] [Related]
8. 15-Deoxy-Delta12,14-prostaglandin J2 inhibits angiotensin II-induced fibronectin expression via hepatocyte growth factor induction in human peritoneal mesothelial cells. Yokoyama Y, Masaki T, Kiribayashi K, Nakashima A, Kokoroishi K, Ogawa T, Kohno N, Yorioka N. Ther Apher Dial; 2010 Feb 01; 14(1):43-51. PubMed ID: 20438519 [Abstract] [Full Text] [Related]
12. 15-Deoxy-delta 12,14-prostaglandin J2 (15d-PGJ 2) sensitizes human leukemic HL-60 cells to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis through Akt downregulation. Han H, Shin SW, Seo CY, Kwon HC, Han JY, Kim IH, Kwak JY, Park JI. Apoptosis; 2007 Nov 01; 12(11):2101-14. PubMed ID: 17786557 [Abstract] [Full Text] [Related]
13. 15d-prostaglandin J2 inhibits inflammatory hypernociception: involvement of peripheral opioid receptor. Napimoga MH, Souza GR, Cunha TM, Ferrari LF, Clemente-Napimoga JT, Parada CA, Verri WA, Cunha FQ, Ferreira SH. J Pharmacol Exp Ther; 2008 Jan 01; 324(1):313-21. PubMed ID: 17928570 [Abstract] [Full Text] [Related]
14. The 15-deoxy-Delta12,14-prostaglandin J2 inhibits LPS-stimulated AKT and NF-kappaB activation and suppresses interleukin-6 in osteoblast-like cells MC3T3E-1. Jung WK, Park IS, Park SJ, Yea SS, Choi YH, Oh S, Park SG, Choi IW. Life Sci; 2009 Jul 03; 85(1-2):46-53. PubMed ID: 19409914 [Abstract] [Full Text] [Related]
15. 15d-PGJ2 induces apoptosis by reactive oxygen species-mediated inactivation of Akt in leukemia and colorectal cancer cells and shows in vivo antitumor activity. Shin SW, Seo CY, Han H, Han JY, Jeong JS, Kwak JY, Park JI. Clin Cancer Res; 2009 Sep 01; 15(17):5414-25. PubMed ID: 19690198 [Abstract] [Full Text] [Related]
16. 15-deoxy-delta 12,14-prostaglandin J2 prevents inflammatory response and endothelial cell damage in rats with acute obstructive cholangitis. Watanabe K, Yokoyama Y, Kokuryo T, Kawai K, Kitagawa T, Seki T, Nakagawa A, Nagino M. Am J Physiol Gastrointest Liver Physiol; 2010 Mar 01; 298(3):G410-8. PubMed ID: 20056897 [Abstract] [Full Text] [Related]
17. The thiazolidinedione drug troglitazone up-regulates nitric oxide synthase expression in vascular endothelial cells. Goya K, Sumitani S, Otsuki M, Xu X, Yamamoto H, Kurebayashi S, Saito H, Kouhara H, Kasayama S. J Diabetes Complications; 2006 Mar 01; 20(5):336-42. PubMed ID: 16949522 [Abstract] [Full Text] [Related]
18. The biphasic effects of cyclopentenone prostaglandins, prostaglandin J(2) and 15-deoxy-Delta(12,14)-prostaglandin J(2) on proliferation and apoptosis in rat basophilic leukemia (RBL-2H3) cells. Emi M, Maeyama K. Biochem Pharmacol; 2004 Apr 01; 67(7):1259-67. PubMed ID: 15013841 [Abstract] [Full Text] [Related]
19. The role of 15-deoxy-delta(12,14)-prostaglandin J(2), an endogenous ligand of peroxisome proliferator-activated receptor gamma, in tumor angiogenesis. Kim EH, Surh YJ. Biochem Pharmacol; 2008 Dec 01; 76(11):1544-53. PubMed ID: 18771658 [Abstract] [Full Text] [Related]
20. 15-deoxy-Delta(12,14)-prostaglandin J2 inhibits G2-M phase progression in human breast cancer cells via the down-regulation of cyclin B1 and survivin expression. Kamagata C, Tsuji N, Moriai M, Kobayashi D, Watanabe N. Breast Cancer Res Treat; 2007 May 01; 102(3):263-73. PubMed ID: 17028981 [Abstract] [Full Text] [Related] Page: [Next] [New Search]